-
Labfolder Deployed Across Max Planck Society
Bio-IT World Brief | Labfolder and the Max Planck Society today announced a licensing agreement to provide up to 11,000 Max Planck scientists from all disciplines ranging from physics, chemistry, life sciences and humanities with labfolder’s laboratory data management digital platform.
Oct 11, 2016
-
Q&A Confirming Next-Gen Sequencing Results with Sanger
The Scientist | Ambry Genetics CEO Aaron Elliott discusses his team's recent analysis of 20,000 clinical next-generation sequencing panels.
Oct 11, 2016
-
Panasas, HGST Offer iRODS Solution
Bio-IT World Brief | Yesterday Panasas and HGST announced a solution using iRODS to link the Panasas ActiveStor storage system with HGST’s object storage Active Archive System.
Oct 7, 2016
-
Bill Gates Succumbs to Moonshot Madness
Omics! Omics! Blog | Keith Robison comments on what he calls a misguided call for a moonshot in human disease from Bill Gates. Gates recently laid out four goals for disease prevention he believes can be attained in the next decade.
Oct 7, 2016
-
Biotech Billionaire Backs Company Geared At Ending Food Allergies
Forbes | Before Brands, a business that wants to prevent food allergies before they even start, launched this morning with $13.1 million in funding from backers including Gurnet Point, run by biotech billionaire Ernesto Bertarelli.
Oct 6, 2016
-
Dramatic Twists Could Upend Patent Battle Over CRISPR Genome-Editing Method
Science | AAAS | Unusual maneuver in CRISPR patent battle could divide spoils, but French company Cellectis also lays claim.
Oct 6, 2016
-
Rumors, Expectations Surround Apple Expansion Into Health Care
POLITICO | The tech giant is cementing partnerships with big health systems and hiring scores of health care professionals.
Oct 5, 2016
-
Gene Editing Takes the Stage at Discovery on Target 2016
Bio-IT World | In the Advances in Gene Editing, Gene Silencing, and Gene Therapy Tracks at the 2016 Discovery on Target conference, we heard from researchers on their exciting new advancements in CRISPR-CAS9 and beyond. The implications for cancer, anti-viral therapies, genetic diseases, and organ transplantation are vast.
Oct 4, 2016
-
Azure is becoming the first AI supercomputer says Microsoft
ZDNet | Microsoft's CEO on how its cloud computing service is evolving.
Oct 4, 2016
-
Biotech PR Needs to Deliver More Signal Less Noise
Forbes | It's hard to know how to get attention for your news these days. The Cambrian explosion of information on the Internet over the past decade has created a confusing world. PR firms have stepped right up to help biotech companies navigate it.
Oct 4, 2016
-
BARDA Awards Contract to DNAe to Develop Semiconductor DNA Sequencing Platform
Bio-IT World Brief | DNAe announced that BARDA has awarded the company a contract worth up to $51.9 million to develop its sequencing platform for rapid diagnosis in two key applications; antimicrobial resistant infections and influenza.
Oct 3, 2016
-
Oxford Nanopore’s Plans for Pre-Packaged Cas9 Test Kits
Bio-IT World | Oxford Nanopore Technologies is seeing more of a demand to focus on a subset of input materials, Clive Brown said this morning in his technical update. In addition to new pores, new chemistries, and updates on various devices, Brown dove into a Cas9 application that the company has been exploring and intimated that Oxford Nanopore will soon begin selling specific test kits for its mobile sequencers.
Sep 29, 2016
-
Oxford Nanopore Announces New Pores, Kits and Updates on Projects
Bio-IT World | The Chief Technology Officer at Oxford Nanopore gave a technical Oxford Nanopore update this morning, outlining updates on MinION, PromethION, SmidgeION, hardware and chemistries.
Sep 29, 2016
-
Cloud Pharmaceuticals, Rubicon Genomics, Bioz and more: News from September 2016
Bio-IT World News Briefs | News, products, and partnerships from around the bio-IT community including news from Cloud Pharmaceuticals, Rubicon Genomics, Bioz, and more.
Sep 29, 2016
-
Despite the Hype Over Gene Therapy Few Drugs Are Close to Approval
MIT Technology Review | There are hundreds of early clinical trials, but only a handful of late-stage ones have reached completion.
Sep 29, 2016
-
Why Big Pharma Wants To Collect 2 Million Genomes
Nature News & Comment | For the head of AstraZeneca's genomics initiative, the challenge is not just getting the sequences, but in putting them to use - wisely.
Sep 28, 2016
-
Microsoft Goes All in for FPGAs to Build Out AI Cloud
TOP500 Supercomputer Sites | Microsoft has revealed that Altera FPGAs have been installed across every Azure cloud server, creating what the company is calling "the world's first AI supercomputer."
Sep 28, 2016
-
Addressing Common Roadblocks In Drug Development: Keynotes At 2016 Discovery On Target
Bio-IT World | There is tremendous unlocked potential for new therapeutic drugs. Some of the key aspects of drug development were addressed with novel solutions in compelling plenary keynote talks at the 2016 Discovery on Target Conference in Boston last week.
Sep 28, 2016
-
Color Genomics Raises $45 Million To Expand Genetic Testing
Bloomberg | Color Genomics Inc., the three-year-old startup aiming to democratize genetic testing, sealed $45 million in funding as it seeks to make its tests for cancer more affordable and accessible, the company announced Tuesday.
Sep 27, 2016
-
Kite Unveils Anticipated CAR-T Cancer Data Positive But Not Complete
Xconomy | Kite Pharma has dipped into a highly anticipated clinical trial of its cancer treatment, KTE-C19, to release a partial set of data. Although not complete, the data bolster the view that Kite could be the first among its peers to win the FDA's green light.
Sep 27, 2016